Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tatsuhiro, Joki"'
Autor:
Masato Matsushima, Yasuki Fujinuma, Masayasu Seki, Tatsuhiro Joki, Hideo Okonogi, Yasuhiko Miura, Iwao Ohno, Jun Hiramoto
Publikováno v:
BMJ Open, Vol 12, Iss 7 (2022)
Objective To evaluate changes in the learning attitudes of primary care physicians.Design Qualitative study through one focus group interview with the programme’s participants. Analysis of the focus group content using the Steps for Coding and Theo
Externí odkaz:
https://doaj.org/article/06ff6a664295440684335ddf4e11e0e7
Autor:
Masayasu Seki, Yasuki Fujinuma, Masato Matsushima, Tatsuhiro Joki, Hideo Okonogi, Yasuhiko Miura, Iwao Ohno, Jun Hiramoto
Publikováno v:
BMJ open. 12(7)
ObjectiveTo evaluate changes in the learning attitudes of primary care physicians.DesignQualitative study through one focus group interview with the programme’s participants. Analysis of the focus group content using the Steps for Coding and Theori
Autor:
Tatsuhiro Joki, Hideo Okonogi, Masayasu Seki, Masato Matsushima, Yasuki Fujinuma, Iwao Ohno, Yasuhiko Miura
Publikováno v:
International Journal of Medical Education
Objectives This study aimed to identify training needs among primary care physicians in Japan who had no formal primary care training. Methods We conducted a focus group interview with seven Japanese primary care physicians who had not previously und
Autor:
Tetsunori Tasaki, Yuta Suzuki, Yuichi Murayama, Toshifumi Ohkusa, Kazumi Hayashi, Takao Arai, Tatsuhiro Joki, Ryosuke Mori, Nobuyuki Watanabe, Takaaki Yanagisawa, Yohei Yamamoto, Hideo Komita, Tetsuro Kikuchi, Toshihide Tanaka, Yasuharu Akasaki, Shigeo Koido, Sadamu Homma
Publikováno v:
Cancer Immunology, Immunotherapy. 65:1499-1509
This trial was designed to evaluate the safety and clinical responses to a combination of temozolomide (TMZ) chemotherapy and immunotherapy with fusions of DCs and glioma cells in patients with glioblastoma (GBM). GBM patients were assigned to two gr
Autor:
Yuta Suzuki, Satoshi Matsushima, Masahiro Ikegami, Kostadin Karagiozov, Yuichi Murayama, Satoshi Ikeuchi, Tatsuhiro Joki, Ryosuke Mori, Yasuharu Akasaki, Junko Takahashi-Fujigasaki, Yoshinobu Manome
Publikováno v:
Brain Tumor Pathology. 33:40-49
Recent advances in genomic technology and genome-wide analysis have identified key molecular alterations that are relevant to the diagnosis and prognosis of brain tumors. Molecular information such as mutations in isocitrate dehydrogenase (IDH) genes
Autor:
Tatsuhiro Joki, Yuichi Murayama, Ryosuke Mori, Kostadin Karagiozov, Yoshinori Matsuwaki, Toshiaki Abe
Publikováno v:
World Neurosurgery. 79:319-326
Objective We report our initial experience of real-time intraoperative C-arm computed tomography (C-arm CT: DynaCT)–guided navigation surgery for pituitary tumors. Methods Recent advancement in flat panel technology makes it possible to obtain CT-l
Autor:
Ryosuke Mori, Tatsuhiro Joki, Junko Takahashi-Fujigasaki, Naoko Inoshita, Shozo Yamada, Takeshi Fujii, Toshiaki Abe, Hiroshi Nishioka
Publikováno v:
ISRN Endocrinology
The aim of this study was to clarify the relationship between the histological features of GH-producing adenomas surgically resected at the Toranomon Hospital and the clinical features of the patients. Histological examinations, including immunohisto
Autor:
Tatsuhiro Joki, Jun Takei, Toshiaki Abe, Toshihiro Ishibashi, Kengo Nishimura, Koichi Misaki, Ichiro Yuki, Hideki Arakawa, Masataka Kato, Hiroki Ohashi, Yuichi Murayama
Publikováno v:
Journal of Neuroendovascular Therapy. 7:323-329
Autor:
Koreaki Irie, Hiroyasu Nagashima, Satoshi Tani, Hideki Arakawa, Akira Isoshima, Hiroyuki Takao, Satoshi Ikeuchi, Masaki Ebara, Masataka Kato, Hiroki Ohashi, Toshiaki Abe, Toshihiro Ishibashi, Yuichi Murayama, Tatsuhiro Joki, Takayuki Saguchi
Publikováno v:
Neurosurgery. 68:1427-1433
Background Fully equipped high-end digital subtraction angiography (DSA) within the operating room (OR) environment has emerged as a new trend in the fields of neurosurgery and vascular surgery. Objective To describe initial clinical experience with
Autor:
Yohei Yamamoto, Toshihide Tanaka, Tetsuro Kikuchi, Toshiaki Abe, Yasuharu Akasaki, Masaki Irie, Takao Arai, Tatsuhiro Joki
Publikováno v:
Journal of Immunotherapy. 34:121-128
Apart from generating T-helper (Th) effector responses, dendritic cells (DCs) are capable of initiating tolerance against the inciting antigens. Therefore, successful DC-based immunotherapy against malignant tumors requires an additional strategy to